Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 209,000
+3,000 (1.46%)
Apr 24, 2026, 3:30 PM KST
Celltrion Earnings Call Transcripts
Fiscal Year 2024
-
Management outlined a shift from biosimilars to innovation, robust sales growth targets through 2027, and a major push into CDMO/CRDMO with global R&D expansion. Shareholder value will be enhanced via buybacks, dividends, and disciplined capital allocation.